Dr. Reddys Laboratories Ltd.

Dr.Reddy's Laboratories has informed regarding completion of GMP inspection by USFDA of its API facility at Bollaram (CTO3) with zero observations and receipt of EIR for closure of the USFDA inspection conducted at FTO SEZ PU2.

The above information is a part of company’s filings submitted to BSE.